Systemic gene therapy for cardiovascular disease

Trends in Cardiovascular Medicine

Volumn 9, Issue 6, 1999, Pages 158-162

  Ponder, Katherine Parker ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; APOLIPOPROTEIN A1; ATRIAL NATRIURETIC FACTOR; COMPLEMENTARY RNA; INSULIN; KALLIKREIN; LIPOPROTEIN RECEPTOR; PROTEIN C; TISSUE PLASMINOGEN ACTIVATOR; VIRUS VECTOR;

ANIMAL MODEL; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW; THROMBOSIS;

ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MICE; RABBITS; RATS; THROMBOEMBOLISM;

EID: 0032805693     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(99)00023-7     Document Type: Review

References (51)

1. Benoit P., Emmanuel F., Caillaud J.M.et al. Somatic gene transfer of human ApoA-I inhibits atherosclerosis progression in mouse models. Circulation. 99:1999;105-110.
2. Bohl D., Naffakh N., Heard J.M. Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts. Nat Med. 3:1997;299-305.
3. Bosch A., McCray P.B., Chang S.M.W.et al. Proliferation induced by keratinocyte growth factor enhances in vivo retroviral vector-mediated gene transfer to mouse hepatocytes. J Clin Invest. 98:1996;2683-2687.
4. Burcin M.M., Schiedner G., Kochanek S., Tsai S.Y., O'Malley B.W. Adenovirus-mediated regulable target gene expression in vivo. Proc Natl Acad Sci U S A. 96:1999;355-360.
5. Cai S.R., Kennedy S.C., Bowling W.M., Flye M.W., Ponder K.P. Therapeutic levels of functional human protein C in rats after retroviral vector-mediated hepatic gene therapy. J Clin Invest. 101:1998;2831-2841.
6. Carmeliet P., Stassen J.-M., Van Vlaenderen I.et al. Adenovirus-mediated transfer of tissue-type plasminogen activator augments thrombolysis in tissue-type plasminogen activator-deficient and plasminogen activator inhibitor-1-overexpressing mice. Blood. 90:1997;1527-1534.
7. Chang P.L., Van Raamsdonk J.M., Hortelano G., Barsoum S.C., MacDonald N.C., Stockley T.L. The in vivo delivery of heterologous proteins by microencapsulated recombinant cells. Trends Biotechnol. 17:1999;78-83.
8. Chao J., Zhang J.J., Lin K.F., Chao L. Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats. Hum Gene Ther. 9:1998;21-31.
9. Cherington V., Chiang G.G., McGrath C.A.et al. Retroviral vector-modified bone marrow stromal cells secrete biologically active factor IX in vitro and transiently deliver therapeutic levels of human factor IX to the plasma of dogs after reinfusion. Hum Gene Ther. 9:1998;1397-1407.
10. Chowdhury J.R., Grossman M., Gupta S., Chowdhury N.R., Baker J.R. Jr., Wilson J.M. Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. Science. 254:1991;1802-1805.
11. Daly T.M., Okuyama T., Vogler C., Haskins M.E., Muzyczka N., Sands M.S. Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice. Hum Gene Ther. 10:1999;85-94.
12. Gao C., Jokerst R., Gondipalli P., Cai S.R., Kennedy S., Ponder K.P. Intramuscular injection of an adenoviral vector expressing hepatocyte growth factor facilitates hepatic transduction with a retroviral vector in mice. Hum Gene Ther. 10:1999;911-922.
13. Gerard R.D., Collen D. Adenovirus gene therapy for hypercholesterolemia, thrombosis and restenosis. Cardiovasc Res. 35:1997;451-458.
14. Grossman M., Rader D.J., Muller D.W.et al. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med. 1:1995;1148-1154.
15. Hansson L., Zanchetti A., Carruthers S.G. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension. principal results of the Hypertension Optimal Treatment (HOT) randomised trial Lancet. 351:1998;1755-1762.
16. Herzog R.W., High K.A. Problems and prospects in gene therapy for hemophilia. Curr Opin Hematol. 5:1998;321-326.
17. Ishibashi S., Brown M.S., Goldstein J.L., Gerard R.D., Hammer R.E., Herz J. Hypercholesterolemia in low density receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest. 92:1993;883-893.
18. Kafri T., Blomer U., Peterson D.A., Gage F.H., Verma I.M. Sustained expression of genes delivered into liver and muscle by lentiviral vectors. Nat Genet. 17:1997;314-317.
19. Kashyap V.S., Santamarina-Fojo S., Brown D.R.et al. Apolipoprotein E deficiency in mice. gene replacement and prevention of atherosclerosis using adenoviral vectors J Clin Invest. 96:1995;1612-1620.
20. Kessler P.D., Podsakoff G.M., Chen X.et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci U S A. 93:1996;14,082-14,087.
21. Kobayashi K., Oka K., Forte T.et al. Reversal of hypercholesterolemia in low density lipoprotein knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor. J Biol Chem. 271:1996;6852-6860.
22. Kolodka T.M., Finegold M., Moss L., Woo S.L. Gene therapy for diabetes mellitus in rats by hepatic expression of insulin. Proc Natl Acad Sci U S A. 92:1995;3293-3297.
23. Kozarsky K.F., McKinley D.R., Austin L.L., Raper S.E., Stratford-Perricaudet L.D., Wilson J.M. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenovirus. J Biol Chem. 269:1994;13,695-13,702.
24. Kozarsky K.F., Jooss K., Donahee M., Strauss J.F. 3rd, Wilson J.M. Effective treatment of familial hypercholesterolemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor. Nat Genet. 13:1996;54-62. a.
25. Kozarsky K.F., Bonen D.K., Giannoni F., Funahashi T., Wilson J.M., Davidson N.O. Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (apobec-1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbits. Hum Gene Ther. 7:1996;943-957. b -.
26. Lawson M.L., Gerstein H.C., Tsui E., Zinman B. Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes. A systematic review and meta-analysis. Diabetes Care. 22:1999;B35-B39.
27. Le M.-T., Okuyama T., Cai S.-R.et al. Therapeutic levels of functional human Factor X in rats after retroviral-mediated hepatic gene therapy. Blood. 89:1997;1254-1259.
28. Li J., Fang B., Eisensmith R.C.et al. In vivo gene therapy for hyperlipidemia. phenotypic correction in Watanabe rabbits by hepatic delivery of the rabbit LDL receptor gene J Clin Invest. 95:1995;768-773.
29. Lin K.F., Chao J., Chao L. Atrial natriuretic peptide gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in salt-sensitive rats. Hum Gene Ther. 9:1998;1429-1438.
30. Lin K.F., Chao J., Chao L. Atrial natriuretic peptide gene delivery reduces stroke-induced mortality rate in Dahl salt-sensitive rats. Hypertension. 33:1999;219-224.
31. Martens J.R., Reaves P.Y., Lu D.et al. Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy. Proc Natl Acad Sci U S A. 95:1998;2664-2669.
32. Meng X., Sawamura D., Tamai K., Hanada K., Ishida H., Hashimoto I. Keratinocyte gene therapy for systemic diseases. Circulating interleukin. 10(released from gene-transferred keratinocytes inhibits contact hypersensitivity at distant areas of the skin. J Clin Invest 101):1998;1462-1467.
33. Nabel E.G. Gene therapy for cardiovascular diseases. J Nucl Cardiol. 6:1999;69-75.
34. O'Byrne S., Caulfield M. Genetics of hypertension. Therapeutic implications. Drugs. 56:1998;203-214.
35. Patijn G.A., Lieber A., Meuse L., Winther B., Kay M.A. High-efficiency retrovirus-mediated gene transfer into the livers of mice. Hum Gene Ther. 9:1998;1449-1456. a.
36. Patijn G.A., Lieber A., Schowalter D.B., Schwall R., Kay M.A. Hepatocyte growth factor induces hepatocyte proliferation in vivo and allows for efficient retroviral-mediated gene transfer in mice. Hepatology. 28:1998;707-716. b.
37. Pedersen T.R. Coronary artery disease. the Scandinavian Simvastatin Survival Study Am J Cardiol. 82:1998;53T-56T.
38. Rendahl K.G., Leff S.E., Otten G.R.et al. Regulation of gene expression in vivo following transduction by two separate rAAV vectors. Nat Biotechnol. 16:1998;757-761.
39. Rettinger S.D., Kennedy S.C., Wu X. Liver-directed gene therapy. quantitative evaluation of promoter elements by using in vivo retroviral transduction Proc Natl Acad Sci U S A. 91:1994;1460-1464.
40. Robbins P.D., Ghivizzani S.C. Viral vectors for gene therapy. Pharmacol Ther. 80:1998;35-47.
41. Simioni P., Sanson B.J., Prandoni P.et al. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost. 81:1999;198-202.
42. Snyder R.O., Miao C.H., Patijn G.A.et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet. 16:1997;270-275.
43. Stevenson S.C., Marshall-Neff J., Teng B., Lee C.B., Roy S., McClelland A. Phenotypic correction of hypercholesterolemia in apoE-deficient mice by adenovirus-mediated in vivo gene transfer. Arterioscler Thromb Vasc Biol. 15:1995;479-484.
44. Taniguchi H., Fukao K., Nakauchi H. Constant delivery of proinsulin by encapsulation of transfected cells. Surg Res. 70:1997;41-45.
45. Tsukamoto K., Smith P., Glick J.M., Rader D.J. Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice. J Clin Invest. 100:1997;107-114.
46. Vassalli G., Dichek D.A. Gene therapy for arterial thrombosis. Cardiovasc Res. 35:1997;459-469.
47. Yayama K., Wang C., Chao L., Chao J. Kallikrein gene delivery attenuates hypertension and cardiac hypertrophy and enhances renal function in Goldblatt hypertensive rats. Hypertension. 31:1998;1104-1110.
48. Ye X., Rivera V.M., Zoltick P.et al. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science. 283:1999;88-91.
49. Wivel N.A., Wilson J.M. Methods of gene delivery. Hematol Oncol Clin North Am. 12:1998;483-501.
50. Zoller B., Garcia de Frutos P., Hillarp A., Dahlback B. Thrombophilia as a multigenic disease. Haematologica. 84:1999;59-70.
51. Zsigmond E., Kobayashi K., Tzung K.W., Li L., Fuke Y., Chan L. Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice. Hum Gene Ther. 8:1997;1921-1933.